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Abstract. Optical Coherence Tomography (OCT) is the primary imag-
ing modality for detecting pathological biomarkers associated to retinal
diseases such as Age-Related Macular Degeneration. In practice, clinical
diagnosis and treatment strategies are closely linked to biomarkers visi-
ble in OCT volumes and the ability to identify these plays an important
role in the development of ophthalmic pharmaceutical products. In this
context, we present a method that automatically predicts the presence
of biomarkers in OCT cross-sections by incorporating information from
the entire volume. We do so by adding a bidirectional LSTM to fuse
the outputs of a Convolutional Neural Network that predicts individ-
ual biomarkers. We thus avoid the need to use pixel-wise annotations to
train our method and instead provide fine-grained biomarker informa-
tion regardless. On a dataset of 416 volumes, we show that our approach
imposes coherence between biomarker predictions across volume slices
and our predictions are superior to several existing approaches.
1 Introduction
Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)
are chronic sight-threatening conditions that affect over 250 million people world
wide [1]. To diagnose and manage these diseases, Optical Coherence Tomogra-
phy (OCT) is the standard of care to image the retina safely and quickly (see
Fig. 1). However, with a growing global patient population and over 30 million
volumetric OCT scans acquired each year, the resources needed to assess these
has already surpassed the capacity of knowledgeable experts to do so [1].
For ophthalmologists, identifying biological markers of the retina, or biomark-
ers, plays a critical role in both clinical routine and research. Biomarkers can
include the presence of different types of fluid buildups in the retina, retinal
shape and thickness characteristics, the presence of cysts, atrophy or scar tis-
sue. Beyond this, biomarkers are paramount to assess disease severity in clinical
routine and have a major role in the development of new pharmaceutical thera-
peutics. With over a dozen clinical and research biomarkers, their identification
is both challenging and time consuming due to their number, size, shape and
extent.
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Fig. 1. (left) Example of an OCT volume of a patient with AMD. Slices are misaligned,
even after post-processing registration. (right) four slices extracted from the volume,
each containing a different set of biomarkers indicated for each image.
To support clinicians with OCT-based diagnosis, numerous automated meth-
ods have attempted to segment and identify specific biomarkers from OCT scans.
For instance, retinal layer [2,3,4] and fluid [4] segmentation, as well as drusen
detection [5] have previously been proposed. While these methods perform well,
they are limited in the number of biomarkers they consider at a time and of-
ten use pixel-wise annotations to train supervised machine learning frameworks.
Given the enormous annotation task involved in manually segmenting volumes,
they are often trained and evaluated on relatively small amounts of data (20 to
100 volumes) [2,4,6].
Instead, we present a novel strategy that automatically identifies the presence
of a wide range of biomarkers throughout an OCT volume. Our method does
not require biomarker segmentation annotations, but rather biomarker tags as to
which are present on a given OCT slice. Using a large dataset of OCT slices and
annotated tags, our approach then estimates all biomarkers on each slice of a
new volume separately. We do this first seperately, without considering adjacent
slices, as these are typically highly anisotropic and not aligned within the volume.
We then treat these predictions as sufficient statistics for each slice and impose
biomarker coherence across slices using a bidirectional Long short-term memory
(LSTM) neural network [7]. By doing so, we force our network to learn the
wanted biomarker co-dependencies within the volume from slice predictions only,
so as to avoid dealing with anisotropic and non-registered slices common in OCT
volumes. We show in our experiments that this leads to superior performances
over a number of existing methods.
2 Method
We describe here our approach for predicting biomarkers across all slices in an
OCT volume. Formally, we wish to predict the presence of B different biomarkers
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in a volume using a deep network, f : [0, 1]S×W×H → [0, 1]S×B , that maps
from a volume of S slices, X ∈ [0, 1]S×W×H , to a set of predicted probabilities
Yˆ ∈ [0, 1]S×B . We denote Yˆsb as the estimated probability that biomarker b
occurs in slice s.
While there are many possible network architectures for f , one simple ap-
proach would be to express f as S copies of the same CNN, f ′ : [0, 1]W×H →
[0, 1]B , whereby each slice in the volume is individually predicted. However, such
an architecture ignores the fact that biomarkers are deeply correlated across an
entire volume. The other extreme would be to define f as a single 3D CNN.
Doing so however would be difficult because (1) 3D CNNs assume spatial coher-
ence in their convolutional layers and (2) the output of f would be of dimension
[0, 1]S×B . While (1) strongly violates OCT volume structure because there are
they typically display non-rigid transformations between consecutive OCT slices,
(2) would imply training with an enormous amount of training data.
For these reasons, we take an intermediate approach between the above
mentioned extremes and express our network as a composition f = fV ◦ fS ,
where fS : [0, 1]S×W×H → RS×D processes slices individually and produces a
D-dimensional descriptor for each slice. Then, fV : RS×D → [0, 1]S×B fuses
all S slice descriptors and predicts the biomarker probabilities for each slice,
whereby taking into account the information of the entire volume. Fig. 2 depicts
our framework and we detail each of its components in the subsequent sections.
2.1 Slice network fS
When presented with a volume X, fS processes each slice independently using
the same slice convolutional network, f ′S : [0, 1]
W×H → RD that maps from a
single slice to a D-dimensional descriptor. The output of fS is then the concate-
nation of the individual descriptors,
fS(X) = [f ′S(X1), . . . , f
′
S(XS)] . (1)
In our experiments, we implemented f ′S as the convolutional part of a Dilated
Residual Network [8] up to the global pooling layer.
2.2 Volume fusion network fV
Let D = fS(X) ∈ RS×D be the set of descriptors of a volume X computed by fS .
The fusion network fV takes D and produces a final probability prediction Yˆ.
The most straightforward architecture for fV would be a multilayer percep-
tion (MLP), which is typical after convolutional layers. However, MLPs make
no assumptions about the underlying nature of the data. Consequently, MLPs
are hard to train, requiring either huge amounts of training data or resort to
aggressive data augmentation techniques, particularly when the dimensionality
of the input space is large as in this case. More importantly, a MLP would ignore
two important aspects about D: (1) the rows of D belong to the same feature
space that share a common distribution; (2) volumes have spatial structure with
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Fig. 2. Overview diagram of our apporach including the CNN, fS , the bidirectional
LSTM, fV , and the output of the fully connected stage. OCT volumes consist of 49
slices.
respect to the biomarkers within them and slices that are nearby to one another
have similar descriptors.
To account for this, we use an LSTM to process slices in a sequential way and
implicitly leverage spatial dependencies, while performing the same operations
on every input (i. e., implicitly assuming a common distribution in the input
space). Formally, our LSTM is a network f` : RD × RH → RH that receives a
descriptor and the previous H-dimensional LSTM state, to produce a new state.
We use the LSTM to iteratively process the descriptors D generating a sequence
of LSTM states,
hi = f`(Ds,hs−1), s = 1, . . . , S, (2)
where Ds is the descriptor on slice s. Additionally, since the underlying distri-
bution of OCT volumes is symmetric3, we use the same LSTM to process the
descriptors backwards,
h′i = f`(Ds,h
′
s+1), s = S, . . . , 1, (3)
generating a second sequence of LSTM states. Initial states are h0 and h
′
S+1,
respectively.
Note that at each position s, hs and h
′
s combine the information from the cur-
rent descriptor Ds with additional information coming from neighboring slices.
We then concatenate both states in a single vector and feed it to a final fully
connected layer fω : R2H → RB that computes the estimated probabilities. The
complete volume fusion network fV is the concatenation of the outputs of fω for
all the slices:
fV(D) = [fω([h1,h′1]), . . . , fω([hS ,h
′
S ])] . (4)
3 Flipping the slice order in a volume produces another statistically correct volume.
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2.3 Training
Training f requires a dataset of M annotated volumes, D = {(X(m),Y(m))}Mm=1
where for each volume X(m) a set of binary labels Y(m) is provided. Y
(m)
sb is 1
if biomarker b is present in slice X
(m)
s . We then use the standard binary cross
entropy as our loss function,
`(Y, Yˆ) = −
∑
s
∑
b
(1−Ysb) log(1− Yˆsb) +Ysb log Yˆsb, (5)
where Yˆ = f(X) is the estimation of our network for a given volume. The goal
during training is then to minimize the expected value of the loss ` over the
training dataset D.
While we could perform this minimization with a gradient-based method in
an end-to-end fashion from scratch, we found that a two-stage training procedure
helped boost performances at test time. In the first stage, we train the slice
network f ′S alone to predict the biomarkers of individual slices. More specifically,
we append a temporary fully connected layer ft : RD → [0, 1]B at the end of f ′S ,
and then minimize a cross entropy loss while presenting to the network randomly
sampled slices from D. In the second stage, we fix the weights of f ′S and minimize
the loss of Eq. (5) for the whole architecture f updating only the weights of the
volume fusion network fV .
3 Experiments
3.1 Data
Our dataset consists of 416 volumes (originating from 327 individuals with Age-
Related Macula Degeneration and Diabetic Retinopathy) whereby each volume
scan consists of S = 49 slices for a total of 20’384 slices. Volumes were obtained
using the Heidelberg Spectralis OCT and each OCT slice has a resolution of
496×512 pixels. Trained annotators provided slice level annotations for 11 com-
mon biomarkers: Subretinal Fluid (SRF), Interetinal Fluid (IRF), Hyperreflec-
tive Foci (HF), Drusen, Reticular Pseudodrusen (RPD), Epiretinal Membrane
(ERM), Geographyic Atrophy (GA), Outer Retinal Atrophy (ORA), Intrareti-
nal Cysts (IRC), Fibrovascular PED (FPED) and Healthy. The dataset was
randomly split 90%/10% for training and testing purposes, making sure that no
volume from the same individual was present in both the training and test sets.
These sets contained a total of 18’179 and 2’205 slices, respectively. The distri-
bution of biomarkers in the training and test sets are reported in Table 1. For
all our experiments, we performed 10-fold cross validation, where the training
set was split into a training (90%) and validation (10%) set.
3.2 Parameters and baselines
For our approach, we set D = 512 for the size of the fS descriptors and H = 512
for the size of the LSTM hidden state. We train the fusion stage using a batch
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size of 4 volumes, while training using SGD with momentum of 0.9 and a base
learning rate of 10−2 which we decrease after 10 epochs of no improvement in
the validation score.
To demonstrate the performance of our approach, we compare it to the fol-
lowing baselines:
– Base: the output of fS (e.g. no slice fusion).
– MLP: output of size 49 × 11 using the 49 × 512 sized feature matrix from
the Base classifier.
– Conv-BLSTM: fuses the last convolutional channels of fS with a size of
(49, 64, 64, 256) and a hidden state of H = 256 channels. This is then followed
by a global pooling and a fully connected layer.
– Conditional Random Field (CRF): trained to learn co-occurrence of
biomarkers within each slice and to smooth the predictions for each biomarker
along different slices of the volume. Logit outputs of the Base classifier are
used as unary terms, and learned pairwise weights are constrained to be
positive to enforce submodularity of the CRF energy. We use the method
from [9] for training and standard graph-cuts for inference at test time.
For all methods we use the same Base classifier and train it as a multi-label
classification task using a learning rate of 10−2, a batch size of 32 with SGD
and a momentum of 0.9. Rotational and flipping data augmentation was applied
during training. We retain the best model for evaluation and do not perform test
time augmentation or cropping. The network was pre-trained on ImageNet [10].
Our primary evaluation metric are the micro and macro mean Average Preci-
sion (mAP). In addition, we also report the Exact Match Ratio (EMR) which is
equal to the percentage of slices predicted without failing to detect any biomarker
in it. The mAP of the CRF baseline is not directly comparable as the CRF out-
put is binary, hence allowing only a single preciscion-recall point to be evaluated.
We therefore also state the maximum F1 scores for each method.
3.3 Results
Table 1 reports the performances of all methods. Using the proposed method
we see an increase in mAP across all biomarkers except for GA and ORA. Both
biomarkers have a very low sample size in the test set. The proposed method
outperforms all other fusion methods in terms of mAP and F1 score and consid-
erably improves over the unfused baseline, which confirms our hypothesis that
inter-slice dependencies can be used to increase the per slice performance. The
poor performance of the Convolutional BLSTM can be explained due to the
misalignment of adjacent slices.
In Fig. 3, we show a typical example illustrating the performance improving
ability of our proposed method. In particular, we show here the prediction of our
approach on each slice for each biomarker and highlight three consecutive slices
of the tested volume (right). For comparison, we also show the corresponding
ground-truth (top left) and the outcome from the Base classifier (middle left).
Here we see that our approach is capable of inferring more accurately the set of
biomarkers across the different slices.
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Biomarker Base MLP Conv-BLSTM CRF Proposed
Healthy (5310/494) 0.797±0.023 0.730±0.025 0.795±0.013 - 0.800±0.022
SRF (942/103) 0.847±0.024 0.796±0.043 0.877±0.030 - 0.905±0.017
IRF (2019/339) 0.691±0.044 0.705±0.039 0.701±0.052 - 0.761±0.047
HF (4261/684) 0.877±0.008 0.839±0.010 0.863±0.018 - 0.896±0.007
Drusen (3990/399) 0.762 ±0.024 0.731±0.024 0.766±0.029 - 0.775±0.038
RPD (1620/146) 0.291±0.044 0.302±0.036 0.288±0.069 - 0.335±0.077
ERM (4338/670) 0.885±0.009 0.849±0.014 0.850±0.022 - 0.903±0.010
GA (897/67) 0.557±0.063 0.234±0.047 0.330±0.049 - 0.556±0.057
ORA (1999/84) 0.151±0.018 0.105±0.008 0.143±0.025 - 0.131±0.019
IRC (3097/553) 0.932±0.006 0.880±0.011 0.928±0.012 - 0.940 ±0.006
FPED (3654/387) 0.931±0.007 0.920 ±0.008 0.936±0.009 - 0.949±0.006
mAP (micro) 0.814±0.006 0.768±0.012 0.794±0.010 0.599±0.003 0.834±0.012
mAP (macro) 0.702±0.008 0.645±0.009 0.680±0.012 0.523±0.006 0.723±0.014
EMR* 0.423±0.015 0.164±0.048 0.413±0.019 0.440±0.003 0.438±0.011
F1* 0.676±0.006 0.502±0.024 0.676±0.011 0.649±0.013 0.694±0.009
Table 1. Experimental results comparing our proposed method to other approaches.
The per-biomaker scores are shown as mean Average Precision (mAP). The train-
ing and test label occurrence is stated beside the biomarker name (training/test). (*)
threshold taken at the max F1 score.
4 Conclusion
We have presented a novel method to identify pathological biomarkers in OCT
slices. Our approach involves detecting biomarkers first slice by slice in the OCT
volume and then using a bidirectional LSTM to coherently adjust predictions.
As far as we are aware, we are the first to demonstrate that such fine-grained
biomarker detection can be achieved in the context of retinal diseases. We have
shown that our approach performs well on a substantial patient dataset out-
performing other common fusion methods. Future efforts will be focused on
extending these results to infer pixel-wise segmentations of found biomarkers
relying solely on the per-image labels.
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